title: Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant.
abstract: The host cell protein cyclophilin A (CypA) binds to CA of human immunodeficiency virus type 1 (HIV-1) and promotes HIV-1 infection of target cells. Disruption of the CypA-CA interaction, either by mutation of the CA residue at G89 or P90 or with the immunosuppressive drug cyclosporine (CsA), reduces HIV-1 infection. Two CA mutants, A92E and G94D, previously were identified by selection for growth of wild-type HIV-1 in cultures of CD4(+) HeLa cell cultures containing CsA. Interestingly, infection of some cell lines by these mutants is enhanced in the presence of CsA, while in other cell lines these mutants are minimally affected by the drug. Little is known about this cell-dependent phenotype of the A92E and G94D mutants, except that it is not dependent on expression of the host factor TRIM5alpha. Here, we show that infection by the A92E and G94D mutants is restricted at an early post-entry stage of the HIV-1 life cycle. Analysis of heterokaryons between CsA-dependent HeLa-P4 cells and CsA-independent 293T cells indicated that the CsA-dependent infection by A92E and G94D mutants is due to a dominant cellular restriction. We also show that addition of CsA to target cells inhibits infection by wild-type HIV-1 prior to reverse transcription. Collectively, these results support the existence of a cell-specific human cellular factor capable of restricting HIV-1 at an early post-entry step by a CypA-dependent mechanism.
authors: Department of Microbiology and Immunology, Vanderbilt University School of Medicine, A-5301 Medical Center North, Nashville, TN 37232-2363, USA.
authors: Chisu
authors: C
authors: Song
authors: Christopher
authors: C
authors: Aiken
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology; D002467:Cell Nucleus / Q000378:metabolism / Q000821:virology; D016572:Cyclosporine / Q000494:pharmacology*; D003593:Cytoplasm / Q000821:virology; D004351:Drug Resistance; D005434:Flow Cytometry; D005799:Genes, Dominant; D015497:HIV-1 / Q000378:metabolism*; D006367:HeLa Cells; D006801:Humans; D009154:Mutation; D010957:Plasmids / Q000378:metabolism; D014771:Virion / Q000378:metabolism; D014779:Virus Replication
chemical_list: D019380:Anti-HIV Agents; D016572:Cyclosporine
references: J Virol. 2006 May;80(10):4683-90
references: 16641261
references: Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5381-5
references: 7777516
references: J Virol. 1998 May;72(5):3845-50
references: 9557668
references: J Virol. 2003 Jul;77(14):7779-85
references: 12829817
references: J Virol. 1994 Feb;68(2):1179-85
references: 8289347
references: Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11920-5
references: 12154231
references: Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13843-8
references: 12368468
references: Nature. 2004 Feb 26;427(6977):848-53
references: 14985764
references: J Med Virol. 1995 Oct;47(2):172-8
references: 8830122
references: J Virol. 2002 May;76(9):4671-7
references: 11932436
references: Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1298-303
references: 12547912
references: Virology. 1998 Nov 10;251(1):1-15
references: 9813197
references: J Virol. 2005 Sep;79(18):11569-79
references: 16140734
references: Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13324-8
references: 15326303
references: Virology. 2000 Mar 15;268(2):294-307
references: 10704338
references: Structure. 1997 Jan 15;5(1):139-46
references: 9016720
references: Nat Struct Biol. 2003 Jun;10(6):475-81
references: 12730686
references: EMBO J. 1999 Dec 1;18(23):6771-85
references: 10581250
references: Science. 1984 Nov 2;226(4674):544-7
references: 6238408
references: Nat Med. 2001 May;7(5):631-4
references: 11329067
references: Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14849-53
references: 16203999
references: Blood. 1988 Dec;72(6):1904-10
references: 2904290
references: J Virol. 2006 Apr;80(8):3712-20
references: 16571788
references: J Virol. 1998 Jan;72(1):303-8
references: 9420228
references: Retrovirology. 2004;1:9
references: 15169567
references: Nature. 1994 Nov 24;372(6504):359-62
references: 7969494
references: EMBO J. 2003 Feb 3;22(3):385-94
references: 12554640
references: J Virol. 2002 Jun;76(11):5667-77
references: 11991995
references: J Immunol. 2006 Jul 1;177(1):443-9
references: 16785541
references: J Virol. 2002 Nov;76(22):11440-6
references: 12388705
references: J Virol. 2005 Jan;79(1):176-83
references: 15596813
references: J Virol. 2004 Apr;78(7):3429-35
references: 15016865
references: J Virol. 1996 Jun;70(6):3551-60
references: 8648689
references: Nat Med. 2003 Sep;9(9):1138-43
references: 12897779
references: Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11827-32
references: 15280539
references: Nature. 1997 Feb 13;385(6617):645-9
references: 9024664
references: J Virol. 1997 Sep;71(9):7110-3
references: 9261445
references: Methods. 1997 Aug;12(4):288-93
references: 9245608
references: EMBO J. 2001 Mar 15;20(6):1300-9
references: 11250896
references: Curr Opin HIV AIDS. 2006 May;1(3):194-9
references: 19372808
references: J Virol. 1996 Jun;70(6):3536-44
references: 8648687
references: Virology. 1996 Aug 1;222(1):279-82
references: 8806510
references: J Virol. 2007 Apr;81(8):3749-56
references: 17267487
references: J Virol. 1995 Apr;69(4):2451-61
references: 7884893
references: Nature. 1989 Feb 2;337(6206):473-5
references: 2644542
references: Methods Cell Biol. 1994;43 Pt A:99-112
references: 7823872
references: Protein Sci. 1997 Nov;6(11):2297-307
references: 9385632
references: Nature. 1994 Nov 24;372(6504):363-5
references: 7969495
references: J Virol. 2007 Feb;81(3):1534-6
references: 17108041
references: Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11914-9
references: 12154227
references: Nat Biotechnol. 2002 Nov;20(11):1151-4
references: 12355096
references: Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15154-9
references: 14657387
references: Antimicrob Agents Chemother. 1994 Aug;38(8):1763-72
references: 7527198
references: Nucleic Acids Res. 2002 Jan 15;30(2):E9
references: 11788735
references: Virology. 2006 Mar 15;346(2):460-8
references: 16375941
references: Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10780-5
references: 15249687
references: J Virol. 1998 Aug;72(8):6430-6
references: 9658084
references: J Virol. 1996 Aug;70(8):5170-6
references: 8764025
references: Cell. 1993 Jun 18;73(6):1067-78
references: 8513493
references: Cell. 1996 Dec 27;87(7):1285-94
references: 8980234
references: J Virol. 2004 Nov;78(21):11739-50
references: 15479815
references: J Virol. 2004 Nov;78(21):12066-70
references: 15479848
references: Nature. 1989 Feb 2;337(6206):476-8
references: 2492638
references: Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10786-91
references: 15249690
references: Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10774-9
references: 15249685
references: J Virol. 2004 Dec;78(23):12800-8
references: 15542632
references: Curr Top Microbiol Immunol. 1996;214:95-131
references: 8791726
references: Nat Med. 1998 Dec;4(12):1397-400
references: 9846577
references: J Mol Biol. 1997 Jun 27;269(5):780-95
references: 9223641
references: J Virol. 1998 Apr;72(4):2846-54
references: 9525604
references: Nature. 2004 Jul 29;430(6999):569-73
references: 15243629